A Study to Compare Laparoscopic to Echographic Assisted Transversus Abdominis Plane Block in Laparoscopic Colectomy
- Conditions
- Laparoscopic ColectomyPain, Postoperative
- Interventions
- Procedure: laparoscopic-assisted Transversus Abdominis Plane (TAP) blockProcedure: ultrasound-assisted Transversus Abdominis Plane (TAP) block
- Registration Number
- NCT04575233
- Lead Sponsor
- Davide La Regina
- Brief Summary
The purpose of this study is to compare the postoperative pain, the time needed and other clinical outcomes in patients who, during laparoscopic colectomy, will be injected with a local anesthetic (Ropivacaine) through an ultrasound guided technique performed by the anaesthesiologist or throught a laparoscopic assisted technique performed by the surgeon
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 116
- Patients candidates to laparoscopic colorectal surgery
- Signed informed consent
- Age < 18 years old
- Pregnancy
- Allergy to local anaesthetics
- Spinal or epidural analgesia
- Acute inflammatory abdominal pathologies
- Chronic pain syndrome
- Contraindications to nonsteroidal anti-inflammatory drugs (NSAIDS)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Laparoscopic Transversus Abdominis Plane (L-TAP) group laparoscopic-assisted Transversus Abdominis Plane (TAP) block Patients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under laparoscopic control Ultrasound Transversus Abdominis Plane (U-TAP) group ultrasound-assisted Transversus Abdominis Plane (TAP) block Patients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under ultrasound control Laparoscopic Transversus Abdominis Plane (L-TAP) group Ropivacaine Patients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under laparoscopic control Ultrasound Transversus Abdominis Plane (U-TAP) group Ropivacaine Patients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under ultrasound control
- Primary Outcome Measures
Name Time Method Opioids consumption 24 hours from surgery Opioid consumption measured in morphine milligram equivalents (MME) per day
- Secondary Outcome Measures
Name Time Method Time required to perform the (Transversus Abdominis Plane) TAP block during procedure Opioid consumption within the first 48 hours after the operation 48 hours from surgery Opioid consumption measured in morphine milligram equivalents (MME) per day
postoperative pain at 3, 6, 12, 24 hours from surgery Postoperative pain on the visual analogue scale (VAS) at 3, 6, 12, 24 hours. This visual analogue scale measures the subjective pain: patients indicate a position along a continuous line between two end-points to specify their level of pain. Absence of pain is represented by 0 while 10 corresponds to the maximum of pain.
length of hospital stay during hospitalization,approximately 6 days number of days the participant is being hospitalized
Trial Locations
- Locations (2)
Ospedale Regionale Bellinzona e Valli, Ente Ospedaliero Cantonale
🇨🇭Bellinzona, Switzerland
Ospedale Regionale di Lugano, Civico e Italiano - Ente Ospedaliero Cantonale
🇨🇭Lugano, Switzerland